Roumen Balabanov to Multiple Sclerosis, Relapsing-Remitting
This is a "connection" page, showing publications Roumen Balabanov has written about Multiple Sclerosis, Relapsing-Remitting.
Connection Strength
0.247
-
Outcomes of natalizumab treatment within 3?years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE. BMC Neurol. 2019 Jun 08; 19(1):116.
Score: 0.162
-
Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis. J Neurol Sci. 2010 Mar 15; 290(1-2):16-21.
Score: 0.084